Brief: Ryvu Therapeutics Signs Max. 10.3 Mln Zloty Funding Deal With NCBR
May 27 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS FUNDING DEAL WITH NATIONAL CENTRE FOR RESEARCH AND
DEVELOPMENT FOR CANCER TREATMENT PROJECT
* TOTAL AMOUNT OF FUNDING ESTIMATED AT MAX. 10.3 MILLION
ZLOTYS
Source text for Workspace: ID:nEM7W6V1Ma
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project